Procaps Group, S.A. (PROCW)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | 242.93 Million USD | 34.03% |
| 2021 | 181.25 Million USD | -59.75% |
| 2020 | 450.28 Million USD | 7.62% |
| 2019 | 418.39 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | 276.78 Million USD | 5.61% |
| 2023 Q1 | 262.09 Million USD | 7.89% |
| 2023 Q3 | 272.36 Million USD | -1.6% |
| 2022 FY | 242.93 Million USD | 34.03% |
| 2022 Q1 | 203.08 Million USD | 12.05% |
| 2022 Q4 | 242.93 Million USD | 7.19% |
| 2022 Q2 | 219.97 Million USD | 8.31% |
| 2022 Q3 | 226.64 Million USD | 3.03% |
| 2021 Q1 | 444.74 Million USD | -1.23% |
| 2021 FY | 181.25 Million USD | -59.75% |
| 2021 Q4 | 181.25 Million USD | 53.02% |
| 2021 Q3 | 118.45 Million USD | -74.77% |
| 2021 Q2 | 469.48 Million USD | 5.56% |
| 2020 Q4 | 450.28 Million USD | 0.0% |
| 2020 FY | 450.28 Million USD | 7.62% |
| 2019 FY | 418.39 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Bright Green Corporation | 1.84 Million USD | -13090.467% |
| Alpha Teknova, Inc. | 1.97 Million USD | -12206.586% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | -157.87% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | -224.125% |
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 44.197% |
| Cosmos Health Inc. | 8.59 Million USD | -2727.83% |
| Journey Medical Corporation | -9.7 Million USD | 2602.132% |
| Embecta Corp. | 1.31 Billion USD | 81.484% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | 47.039% |
| Dynavax Technologies Corporation | 106.63 Million USD | -127.816% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 285.687% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 43.863% |
| PainReform Ltd. | -7.95 Million USD | 3155.748% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 1653.806% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 1653.806% |
| SCYNEXIS, Inc. | -19.35 Million USD | 1355.463% |
| Safety Shot Inc | -2.28 Million USD | 10734.506% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | 2676.234% |
| Theratechnologies Inc. | 24.87 Million USD | -876.768% |
| Harrow Health, Inc. | 116.41 Million USD | -108.674% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | 9740.159% |
| Biofrontera Inc. | 4.05 Million USD | -5889.448% |
| DURECT Corporation | -7.65 Million USD | 3273.922% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 824.586% |
| Cronos Group Inc. | -663.32 Million USD | 136.623% |
| OptiNose, Inc. | 58.06 Million USD | -318.379% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 61.03% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | 1767.115% |
| RedHill Biopharma Ltd. | -5.18 Million USD | 4784.353% |
| Organogenesis Holdings Inc. | 15.01 Million USD | -1518.144% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | 3919.898% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | -227238.83% |
| Radius Health, Inc. | 359.28 Million USD | 32.384% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | -123085.047% |
| ProPhase Labs, Inc. | 19.23 Million USD | -1163.231% |
| Phibro Animal Health Corporation | 454.84 Million USD | 46.59% |
| Procaps Group S.A. | 242.93 Million USD | 0.0% |
| Alvotech | 1.06 Billion USD | 77.175% |
| TherapeuticsMD, Inc. | 3.67 Million USD | -6505.003% |
| Viatris Inc. | 17.13 Billion USD | 98.582% |
| Rockwell Medical, Inc. | 4.45 Million USD | -5351.795% |
| Aytu BioPharma, Inc. | -4.87 Million USD | 5081.177% |
| SIGA Technologies, Inc. | -148.68 Million USD | 263.391% |
| Tilray Brands, Inc. | 158.97 Million USD | -52.81% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | -99.291% |
| Shineco, Inc. | 29.29 Million USD | -729.394% |
| PetIQ, Inc. | 351.93 Million USD | 30.972% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | 8472.843% |
| Incannex Healthcare Limited | -5.48 Million USD | 4529.025% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | -37.017% |
| Alimera Sciences, Inc. | 55.3 Million USD | -339.227% |
| Silver Spike Investment Corp. | -32.61 Million USD | 844.924% |
| Assertio Holdings, Inc. | -32.52 Million USD | 846.817% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | 16418.157% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | 4900.663% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | 5146.365% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 3057.724% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | -5660.778% |
| Hempacco Co., Inc. | 13.61 Million USD | -1684.339% |
| Talphera, Inc. | -5.72 Million USD | 4346.321% |
| Alvotech | 1.06 Billion USD | 77.175% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | -3300.028% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 351.196% |
| Currenc Group, Inc. | -16.57 Million USD | 1565.819% |
| Kamada Ltd. | -46.43 Million USD | 623.205% |
| Indivior PLC | -33.95 Million USD | 815.516% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | -93129.562% |
| Flora Growth Corp. | -713 Thousand USD | 34171.809% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 3057.724% |
| Evolus, Inc. | 63.7 Million USD | -281.321% |
| HUTCHMED (China) Limited | -197.45 Million USD | 223.03% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 49.295% |
| Akanda Corp. | 3.9 Million USD | -6121.184% |